Evaluating the Efficacy and Safety of Direct Oral Anticoagulants Compared to Vitamin K Antagonists in Patients with Antiphospholipid Syndrome: Updated Systematic Review and Meta-Analysis

Background Antiphospholipid Syndrome (APS) is an autoimmune condition that increases thrombosis risk. Although Vitamin K antagonists (VKA) are standard treatment, interest in direct oral anticoagulants (DOAC) has grown. Recent studies evaluated DOAC across all APS subgroups. This review updates our...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Lama Alfehaid PharmD, MME, Nada Alsuhebany PharmD, Hussah Albahlal PharmD, Albatoul Alomran PharmD, Abdulmajeed M Alshehri PharmD, Mohammed AlSheef MD, Abdulaali Almutairi PharmD, PhD
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	SAGE Publishing 2025-08-01
Edice:	Clinical and Applied Thrombosis/Hemostasis
On-line přístup:	https://doi.org/10.1177/10760296251364269
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!